LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

Search

Quanterix Corp

Închisă

SectorSănătate

3.93 2.61

Rezumat

Modificarea prețului

24h

Curent

Minim

3.83

Maxim

4.1

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+96.34% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-111M

185M

Deschiderea anterioară

1.32

Închiderea anterioară

3.93

Sentimentul știrilor

By Acuity

50%

50%

167 / 350 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

25 mar. 2026, 20:20 UTC

Achiziții, Fuziuni, Preluări

Infosys Agrees to Acquire Stratus

25 mar. 2026, 23:58 UTC

Câștiguri

Guming Proposes 2025 Final Dividend of HK$0.50 >1364.HK

25 mar. 2026, 23:58 UTC

Câștiguri

Guming: Seek to Further Expand Coffee Product Line, Explore New Food Categories >1364.HK

25 mar. 2026, 23:57 UTC

Câștiguri

Guming: Aim to Expand Store Network in China, Evaluate Overseas Opportunities >1364.HK

25 mar. 2026, 23:57 UTC

Câștiguri

Guming Store Network Rose 37% on Year to 13,554 Stores as of Dec. 31, 2025 >1364.HK

25 mar. 2026, 23:56 UTC

Câștiguri

Guming 2025 Rev CNY12.91B Vs. CNY8.79B >1364.HK

25 mar. 2026, 23:56 UTC

Câștiguri

Guming 2025 Net CNY3.11B Vs. Net CNY1.48B >1364.HK

25 mar. 2026, 23:41 UTC

Market Talk

Nikkei May Trade Rangebound Amid Uncertainty Over U.S.-Iran Talks -- Market Talk

25 mar. 2026, 23:41 UTC

Câștiguri

These Stocks Are Today's Movers: Arm, Intel, AMD, Firefly Aerospace, Robinhood, JD.com, Sarepta, and More -- Barrons.com

25 mar. 2026, 23:34 UTC

Market Talk
Evenimente importante

Gold Declines on Possible Technical Correction -- Market Talk

25 mar. 2026, 22:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25 mar. 2026, 22:08 UTC

Market Talk

Synlait Milk's Outlook Depends on Dunsandel -- Market Talk

25 mar. 2026, 22:07 UTC

Câștiguri

China Mengniu Dairy: Weak Consumer Demand Weighed on Rev >2319.HK

25 mar. 2026, 22:07 UTC

Câștiguri

China Mengniu Dairy Plans Steady Increase in Dividends For Next Three Years >2319.HK

25 mar. 2026, 22:07 UTC

Câștiguri

China Mengniu Dairy: 2025 Net Supported by Absence of Impairment Provisions Made Last Year >2319.HK

25 mar. 2026, 22:07 UTC

Câștiguri

China Mengniu Dairy 2025 Rev CNY82.24B Vs. CNY88.67B >2319.HK

25 mar. 2026, 22:07 UTC

Câștiguri

China Mengniu Dairy 2025 Net CNY1.55B Vs. Net CNY104.51M >2319.HK

25 mar. 2026, 21:58 UTC

Market Talk

Amplitude Energy Oversold on Isabella-1 Well Disappointment -- Market Talk

25 mar. 2026, 21:37 UTC

Market Talk

Miran: AI and Deregulation Are Positive Supply Shocks To Economy -- Market Talk

25 mar. 2026, 21:14 UTC

Achiziții, Fuziuni, Preluări

St Barbara: Expects to Record Gain on Sale of Roughly A$500 Million Upon Completion

25 mar. 2026, 21:13 UTC

Achiziții, Fuziuni, Preluări

St Barbara: All Conditions Satisfied, Waived on Lingbao Deal

25 mar. 2026, 21:12 UTC

Achiziții, Fuziuni, Preluări

Closing M&A Deals Bring Opportunity. Janus Henderson and Other Stocks to Buy. -- Barrons.com

25 mar. 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

25 mar. 2026, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

25 mar. 2026, 20:33 UTC

Achiziții, Fuziuni, Preluări

KKR & Co.: Entered Agreement to Sell CoolIT Systems to Ecolab in Transaction Valued at $4.75B >KKR >KKR

25 mar. 2026, 20:31 UTC

Câștiguri

The SpaceX IPO Is Coming. Cathie Wood's Ark Venture and More Funds to Get in on the Action. -- Barrons.com

25 mar. 2026, 20:15 UTC

Achiziții, Fuziuni, Preluări

KKR Scores One of Its Best Bets With Sale of Data-Center Cooling Business -- WSJ

25 mar. 2026, 20:15 UTC

Achiziții, Fuziuni, Preluări

CoolIT Employees Set to Receive Average Payouts of $240,000, Executives Say -- WSJ

25 mar. 2026, 20:15 UTC

Achiziții, Fuziuni, Preluări

CoolIT Deal Ranks Among KKR's Top-4 Highest Earning Investments in Past 20 Years, Executives Say -- WSJ

25 mar. 2026, 20:15 UTC

Achiziții, Fuziuni, Preluări

KKR Set to Make 15x Investment From $4.75B Sale of CoolIT to Ecolab, Executives Say -- WSJ

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

96.34% sus

Prognoză pe 12 luni

Medie 7.5 USD  96.34%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

167 / 350 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat